Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Asset Utilization Ratio (2017 - 2025)

Historic Asset Utilization Ratio for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to 0.23.

  • Assembly Biosciences' Asset Utilization Ratio fell 1175.95% to 0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23, marking a year-over-year decrease of 1175.95%. This contributed to the annual value of 0.22 for FY2024, which is 27113.44% up from last year.
  • Per Assembly Biosciences' latest filing, its Asset Utilization Ratio stood at 0.23 for Q3 2025, which was down 1175.95% from 0.37 recorded in Q2 2025.
  • Assembly Biosciences' Asset Utilization Ratio's 5-year high stood at 0.37 during Q2 2025, with a 5-year trough of 0.03 in Q4 2021.
  • Its 5-year average for Asset Utilization Ratio is 0.17, with a median of 0.16 in 2021.
  • The largest annual percentage gain for Assembly Biosciences' Asset Utilization Ratio in the last 5 years was 43949.27% (2021), contrasted with its biggest fall of 8964.83% (2021).
  • Assembly Biosciences' Asset Utilization Ratio (Quarter) stood at 0.03 in 2021, then skyrocketed by 43.72% to 0.04 in 2022, then skyrocketed by 86.08% to 0.08 in 2023, then skyrocketed by 241.95% to 0.26 in 2024, then dropped by 10.8% to 0.23 in 2025.
  • Its Asset Utilization Ratio stands at 0.23 for Q3 2025, versus 0.37 for Q2 2025 and 0.29 for Q1 2025.